Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

September 30, 2005

Conditions
ColonoscopyColonic Polyps
Interventions
DRUG

AQUAVAN® (fospropofol disodium) Injection

DRUG

Midazolam HCl

Trial Locations (20)

10021

Research Associates of New York, New York

11501

Winthrop-University Hospital, Mineola

20815

Chevy Chase Clinical Research, Chevy Chase

21204

Endoscopic Microsurgery Associates, PA, Towson

28801

Asheville Gastroenterology Associates/The Endoscopy Center, Asheville

30342

Atlanta Gastroenterology Associates, Atlanta

35801

Clinical Research Associates, Huntsville

37203

Gastrointestinal Institute, Nashville

37205

St. Thomas Medical Group, P.C., Nashville

38120

Memphis Gastroenterology Group, PC, Memphis

39202

Gastrointestinal Associates, PA, Jackson

47713

Welborn Clinic, Evansville

53215

Wisconsin Center for Advance Research, Milwaukee

61107

Rockford Gastroenterology Associates Ltd., Rockford

70808

Gulf Coast Research Associates, Inc., Baton Rouge

71201

Gastroenterology Clinic, Monroe

74104

Oklahoma Gastroenterology Associates, Tulsa

78215

Alamo Research Center, San Antonio

85023

Arizona Research Center, Phoenix

99207

Spokane Digestive Diseases Center, Spokane

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00125424 - Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy | Biotech Hunter | Biotech Hunter